TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcomeRÜCKER, Frank G; SCHLENK, Richard F; PASCHKA, Peter et al.Blood. 2012, Vol 119, Num 9, pp 2114-2121, issn 0006-4971, 8 p.Article

Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study GroupKRÖNKE, Jan; SCHLENK, Richard F; SPÄTH, Daniela et al.Journal of clinical oncology. 2011, Vol 29, Num 19, pp 2709-2716, issn 0732-183X, 8 p.Article

A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)LISO, Arcangelo; CASTIGLIONE, Filippo; MARTELLI, Massimo F et al.Haematologica (Roma). 2008, Vol 93, Num 8, pp 1219-1226, issn 0390-6078, 8 p.Article

An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AMLBULLINGER, Lars; DÖHNER, Konstanze; POLLACK, Jonathan R et al.Blood. 2008, Vol 111, Num 9, pp 4490-4495, issn 0006-4971, 6 p.Article

Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype : individual patient data-based meta-analysis of the German Acute Myeloid Leukemia IntergroupSCHAICH, Markus; SCHLENK, Richard F; BÜCHNER, Thomas et al.Haematologica (Roma). 2007, Vol 92, Num 6, pp 763-770, issn 0390-6078, 8 p.Article

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group UlmFRÖHLING, Stefan; SCHLENK, Richard F; BREITRUCK, Jochen et al.Blood. 2002, Vol 100, Num 13, pp 4372-4380, issn 0006-4971, 9 p.Article

Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entityTASKESEN, Erdogan; BULLINGER, Lars; SCHLENK, Richard F et al.Blood. 2011, Vol 117, Num 8, pp 2469-2475, issn 0006-4971, 7 p.Article

RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study GroupGAIDZIK, Verena I; BULLINGER, Lars; SPÄTH, Daniela et al.Journal of clinical oncology. 2011, Vol 29, Num 10, pp 1364-1372, issn 0732-183X, 9 p.Article

Prognostic Impact of Minimal Residual Disease in CBFB-MYH11-Positive Acute Myeloid LeukemiaCORBACIOGLU, Andrea; SCHOLL, Claudia; NACHBAUR, David et al.Journal of clinical oncology. 2010, Vol 28, Num 23, pp 3724-3729, issn 0732-183X, 6 p.Article

Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcomeKAYSER, Sabine; SCHLENK, Richard F; DÖHNER, Hartmut et al.Blood. 2009, Vol 114, Num 12, pp 2386-2392, issn 0006-4971, 7 p.Article

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid LeukemiaSCHLENK, Richard F; DÖHNER, Konstanze; SCHLEGELBERGER, Brigitte et al.The New England journal of medicine. 2008, Vol 358, Num 18, pp 1909-1918, issn 0028-4793, 10 p.Article

Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years : results from AMLSG trial AML HD98-BFRÖHLING, Stefan; SCHLENK, Richard F; KAYSER, Sabine et al.Blood. 2006, Vol 108, Num 10, pp 3280-3288, issn 0006-4971, 9 p.Article

Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemiaFROHLING, Stefan; KAYSER, Sabine; MAYER, Cora et al.Haematologica (Roma). 2005, Vol 90, Num 2, pp 194-199, issn 0390-6078, 6 p.Article

Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemiaFRÖHLING, Stefan; SKELIN, Silvia; LIEBISCH, Claudia et al.Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2480-2485, issn 0732-183XArticle

Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: A study of the acute myeloid leukemia study group ulmDÖHNER, Konstanze; TOBIS, Karen; ULRICH, Regina et al.Journal of clinical oncology. 2002, Vol 20, Num 15, pp 3254-3261, issn 0732-183XArticle

High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemiaMETZELER, Klaus H; HEILMEIER, Bernhard; SAUERLAND, Maria C et al.Blood. 2012, Vol 120, Num 10, pp 2118-2126, issn 0006-4971, 9 p.Article

TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study GroupGAIDZIK, Verena I; PASCHKA, Peter; BENTZ, Martin et al.Journal of clinical oncology. 2012, Vol 30, Num 12, pp 1350-1357, issn 0732-183X, 8 p.Article

Prognostic Importance of Histone Methyltransferase MLL5 Expression in Acute Myeloid LeukemiaDAMM, Frederik; OBERACKER, Tina; KANZ, Lothar et al.Journal of clinical oncology. 2011, Vol 29, Num 6, pp 682-689, issn 0732-183X, 8 p.Article

Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid LeukemiaLUGTHART, Sanne; GRÖSCHEL, Stefan; VERHOEF, Gregor et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3890-3898, issn 0732-183X, 9 p.Article

Prognostic Factors in Adult Patients up to 60 Years Old With Acute Myeloid Leukemia and Translocations of Chromosome Band 11q23: Individual Patient Data―Based Meta-Analysis of the German Acute Myeloid Leukemia IntergroupKRAUTER, Jürgen; WAGNER, Katharina; BÜCHNER, Thomas et al.Journal of clinical oncology. 2009, Vol 27, Num 18, pp 3000-3006, issn 0732-183X, 7 p.Article

MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. CommentaryGROSVELD, Gerard C; HEUSER, Michael; RUDOLPH, Cornelia et al.Blood. 2007, Vol 110, Num 5, issn 0006-4971, 1401-1402, 1639-1647 [11 p.]Article

Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of zap-70 and vh mutation status in chronic lymphocytic leukemiaKRÖBER, Alexander; BLOEHDORN, Johannes; LICHTER, Peter et al.Journal of clinical oncology. 2006, Vol 24, Num 6, pp 969-975, issn 0732-183X, 7 p.Article

CD34⁺ cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patientsRINGHOFFER, Mark; WIESNETH, Markus; DÖHNER, Hartmut et al.British journal of haematology. 2004, Vol 126, Num 4, pp 527-535, issn 0007-1048, 9 p.Article

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemiaBULLINGER, Lars; DÖHNER, Konstanze; BAIR, Eric et al.The New England journal of medicine. 2004, Vol 350, Num 16, pp 1605-1616, issn 0028-4793, 12 p.Article

Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative GroupGRÖSCHEL, Stefan; SCHLENK, Richard F; GERMING, Ulrich et al.Journal of clinical oncology. 2013, Vol 31, Num 1, pp 95-103, issn 0732-183X, 9 p.Article